Unknown NA INTERVENTIONAL 2-arm NCT05669898

Continuous Adductor Canal Infusion vs. Single-injection Adductor Canal Block for Total Knee Arthroplasty

Multimodal Analgesia for Unilateral Total Knee Arthroplasty: Impact of Continuous Adductor Canal Infusion Combined With NSAID vs. Intravenous Morphine Patient-controlled Analgesia Combined With Single-injection Adductor Canal Block

Sponsor: Taipei Veterans General Hospital, Taiwan

Conditions Arthroplasty, Replacement, Knee Multimodal Analgesia Pain, Postoperative

Interventions Brief Pain Inventory (Short Form), WOMAC Osteoarthritis index, and Lower extremity functional scale Pain scores (numerical rating scale at rest and motion): will be assessed with numerical rating scale at both rest and motion on both knees. Rehabilitation physiotherapy

Updated 5 times since 2023 Last updated: Mar 9, 2023 Started: May 21, 2019 Primary completion: May 31, 2023 Completion: Jun 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Arthroplasty, Replacement, Knee and Multimodal Analgesia and is currently ongoing. Taipei Veterans General Hospital, Taiwan leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Apr 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Apr 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Apr 2023 — Jul 2024 [monthly]

Recruiting NA
Feb 2023 — Apr 2023 [monthly]

Recruiting NA

First recorded

May 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Taipei Veterans General Hospital, Taiwan

Data source: Taipei Veterans General Hospital, Taiwan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan